Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

March 18, 2025 updated by: Lise Solberg Nes, Oslo University Hospital

Testing a Computerized Interactive Stress Management Intervention in Early Stage Cancer: a Randomized Controlled Trial

The purpose with this study is to test the effect of an app for stress management among patients with a variety of cancer diagnoses.

Study Overview

Status

Active, not recruiting

Detailed Description

A cancer diagnosis and subsequent treatment can be disruptive and traumatic, often accompanied by a multitude of stressors for the patients and their support network. Uncertainty of outcome and invasive medical procedures with aversive side effects are not uncommon, and while people differ widely in how they experience and cope with such challenges, cancer related distress including anxiety, depression, worry and rumination is prevalent. With multiple domains of function impacted it is also not surprising that quality of life (QoL) often is diminished.

Stress management interventions can facilitate adjustment to cancer, including reduced distress and improved quality of life. Unfortunately, many people with cancer do not have the strength or opportunity to attend groups or in-person interventions.

This study will therefore test the effect of an app for stress management among patients with different cancer diagnosis. The app contains 10 modules distributed over five weeks, focusing on education of different techniques for reduction of stress and stress reduction exercises.

The app was tested in a feasibility pilot study among 25 patients with a variety of cancer diagnoses and is now being tested in a randomized controlled trial with a sample of 175 cancer survivors. The participants were randomly assigned to use the 10 module app or to a control group that receive treatment as usual, and will be followed with repeated measures over 12 months.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway
        • Oslo University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with cancer (all diagnosis).
  • Maximum time since completed treatment at hospital: 12 months
  • Patients are > 18 years of age, able to write/read/speak Norwegian and have their own smart phone or tablet

Exclusion Criteria:

• None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: App for Stress management
Participants will get access to two modules per week for five weeks (total 10 modules). The app consists of stress management education, cognitive behavioral interventions and relaxation training exercises.
An app consisting of 10 modules that teaches stress management, cognitive behavioral coping skills and relaxation training.
Other Names:
  • Stress management
No Intervention: Waitlist control group
Participants will get treatment as usual during the study. After the one year study follow up they will receive the stress management app.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Perceived Stress Scale (PSS-14)
Time Frame: Baseline, post intervention follow up at 3, 6, and 12 months
14 item scale measuring perceived stress. Scale range: 0-56. Higher scores indicate higher perceived stress.
Baseline, post intervention follow up at 3, 6, and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SF-36 Item Short Form Health Survey (RAND-36 version)
Time Frame: Baseline, post intervention follow up at 3, 6, and 12 months
36 item scale measuring health related quality of life (HRQoL). The scale has 8 subscales and 1 single item score. Scale and single item range: 0 to 100. Higher scores indicate higher HRQoL.
Baseline, post intervention follow up at 3, 6, and 12 months
The Self-Regulatory Fatigue-18 (SRF-18)
Time Frame: Baseline, post intervention follow up at 3 and 12 months
18 item scale measuring self-regulation. Scale range: 18 to 90. A higher score indicates higher self regulatory fatigue
Baseline, post intervention follow up at 3 and 12 months
The Brief Coping Orientation to Problems (Brief COPE)
Time Frame: Baseline
The outcome measure consists of 14 different scales of different coping strategies with two items per scale, for a total of 28 items. Scale range 2 to 8. Higher scores indicate higer use of the different coping strategies
Baseline
Health, well-being and sleep
Time Frame: Baseline, post intervention follow up at 3, 6, and 12 months
A 5 item measure, measuring health, well-being and sleep on a scale from 0 to 10. Higher scores indicate better health, well-being and sleep
Baseline, post intervention follow up at 3, 6, and 12 months
Intervention commentary
Time Frame: Post intervention (immediately post intervention)
A six item brief measure of participant's intervention reactions. The first 3 items gauged participants' program perception on a scale from 1 to 5, with 5 indicating better perception. The next 3 items were open ended questions: * What did you like best? * What did you like the least? * Suggestions for improvement?
Post intervention (immediately post intervention)
The Hospital Anxiety and Depression Scale (HADS)
Time Frame: Baseline, post intervention follow up at 3, 6, and 12 months
14 item scale measuring anxiety and depression. The Scale has a total score with a scale range of 0 to 42 and an anxiety (HADS-A) and a depression (HADS-D) subscale, both with scale range of 0 to 21. Higer scores indicate higher level of anxiety and depression
Baseline, post intervention follow up at 3, 6, and 12 months
The Distress Thermometer
Time Frame: Baseline, post intervention follow up at 3, 6, and 12 months
One item scale measuring distress on a scale from 0 to 10. Higer scores indicate higher distress
Baseline, post intervention follow up at 3, 6, and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Lise Solberg Nes, PhD, Oslo University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Actual)

August 1, 2020

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

October 17, 2016

First Submitted That Met QC Criteria

October 19, 2016

First Posted (Estimated)

October 20, 2016

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 18, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2016/1436

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on App for stress management

Subscribe